<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL) is characterised by the presence of the t(14;18)(q32;q21) and represents approximately 25% of new cases of non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>While the t(14;18) is a well-documented rearrangement, the role of secondary cytogenetic abnormalities in the development and progression of these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> remains unclear </plain></SENT>
<SENT sid="2" pm="."><plain>Comparative genomic hybridisation was used to characterise changes in DNA copy number in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> DNA from patients with this <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The mean numbers of deletion and amplification events found in each of the 45 samples studied were 1.8 and 2.3, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>Regions of recurrent (&gt;10% <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> samples) gain involved chromosomes 2p13-16 (16%), 7 (20%), 12 (16%), 13q21-33 (18%), 18 (27%), and X (36%) and frequent losses localised to 6q (29%) and 17p (20%) </plain></SENT>
<SENT sid="5" pm="."><plain>Amplification of chromosome 13 represents a novel finding in FL </plain></SENT>
<SENT sid="6" pm="."><plain>The minimal amplified region was refined to a 6.8-Mb interval of 13q32-33 between the BAC clones 88K16 and 44H20 by fluorescence in situ hybridisation studies using metaphase chromosomes derived from <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> material </plain></SENT>
<SENT sid="7" pm="."><plain>There are a number of reports in the literature suggesting that amplification of chromosome 13 also occurs in other human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>The location of the putative oncogene on 13q described here in follicular and transformed <z:hpo ids='HP_0002665'>lymphoma</z:hpo> may also be important in the evolution of many other <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
</text></document>